Status:
COMPLETED
The Effects of Salvia Hispanica-Enriched Foods on Glycemic and Insulinemic Responses and Subjective Satiety
Lead Sponsor:
Unity Health Toronto
Conditions:
Post Prandial Blood Glucose
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Salvia hispanic (Salba) is postulated to increase satiety. This study determines the optimal amount of Salba as well as whether liquid or solid enriched products will produce maximum satiety. The resu...
Detailed Description
There are many factors that are involved in the ability of foods to suppress appetite, for instance the fiber, fat and protein contents of the food. The novel whole grain Salvia hispanica may signific...
Eligibility Criteria
Inclusion
- BMI 20-35 kg/m2
Exclusion
- Endocrine disease (adrenal disorders, glucose homeostasis disorders, metabolic bone diseases, pituitary gland disorders, parathyroid gland disorders, thyroid disorders)
- Pregnancy
- Use of drugs that influence carbohydrate metabolism (e.g. systemic glucocorticoids, beta blockers, thiazide diuretics)
- Use of fiber supplements
- Substance abuse (including regular smoking)
- Digestive or malabsorption disorders (malabsorption syndrome, Crohn's disease, stomach ulcer, duodenal ulcer or intestinal parasites)
- Presence of any significant disease or condition, including emotional or psychiatric disorders, that, in the opinion of the investigator, is likely to alter the metabolic state or interfere with the subject's ability to complete the study
Key Trial Info
Start Date :
December 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2009
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00728065
Start Date
December 1 2007
End Date
February 1 2009
Last Update
February 18 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Nutrition and Risk Factor Modification Centre
Toronto, Ontario, Canada, M5C 2T2